AminoMatrix Labs Co., Ltd.
Embedded Files
We fuse amino acid–metal power to topple superbugs and rescue plants from 'incurable' diseases worldwide.
Fundraising Status
Fundraising Status
Pre-Seed
Revenue (USD)
Revenue (USD)
2025 Target: 5M
Competitor
Competitor
Bayer
Stoller
AEA
Biofeed
Company Details
Short Description
Short Description
AminoMatrix Labs is a pioneering biotech company creating next-generation amino acid–metal complexes that outsmart drug-resistant pathogens in humans and heal once-incurable vascular diseases in plants, forging a healthier planet for all.
Core Technology
Core Technology
Metal-Amino acid Click Synthesis (MACS) Technology: We fuse amino acids and metals to outsmart superbugs and conquer incurable plant diseases, unlocking transformative solutions for human and plant health.
US Objective
Expected Results
Expected Results
Strategic Partnerships: Forge connections with key US investors, industry leaders, and academic institutions to drive future collaborations and funding opportunities.
Market Expansion: Gain valuable exposure and insights into the US market, paving the way for successful entry and growth in both healthcare and agricultural sectors.
Enhanced Credibility: Validate our innovative amino acid–metal technology on an international stage, boosting our reputation and opening doors for further commercialization and research collaborations.
Team Members
Team Members
Grace Li
CEO
Media Exposure
AgriLife Today (English)
Fierce Biotech (English)
https://endpts.com/ (English)
Page updated
Report abuse